The Prevention and Treatment of Restenosis in The Era of Drug-eluting Stent  

作　　者：张敏州 

机构地区：[1]The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

出　　处：《Chinese Journal of Integrative Medicine》2007年第1期6-7,共2页中国结合医学杂志（英文版）

摘　　要：Ever since the first percutaneous transluminal coronary angioplasty （PTCA） was completed successfully by Gruentzig in 1977, postoperational restenosis （RS） has been puzzling constantly the progress of percutaneous coronary intervention （PCI）, and it is known as the Achilles Heel of PCI. In a certain sense, the development history of PCI is also the history of continually overcoming RS.Ever since the first percutaneous transluminal coronary angioplasty （PTCA） was completed successfully by Gruentzig in 1977, postoperational restenosis （RS） has been puzzling constantly the progress of percutaneous coronary intervention （PCI）, and it is known as the Achilles Heel of PCI. In a certain sense, the development history of PCI is also the history of continually overcoming RS.

关 键 词：PCI The Prevention and Treatment of Restenosis in The Era of Drug-eluting Stent 

分 类 号：R541.4[医药卫生—心血管疾病]